fenofibrat terapia 145 mg
sun pharmaceutical industries europe b.v. - olanda - fenofibratum - compr. film. - 145mg - hipocolesterolemiante si hipotrigliceridemiante fibrati
levetiracetam terapia 250 mg
sun pharmaceutical industries europe b.v. - irlanda - levetiracetamum - compr. film. - 250mg - antiepileptice alte antiepileptice
levetiracetam terapia 500 mg
sun pharmaceutical industries europe b.v. - irlanda - levetiracetamum - compr. film. - 500mg - antiepileptice alte antiepileptice
levetiracetam terapia 1000 mg
sun pharmaceutical industries europe b.v. - irlanda - levetiracetamum - compr. film. - 1000mg - antiepileptice alte antiepileptice
etoricoxib terapia 30 mg
sun pharmaceutical industries europe b.v. - olanda - etoricoxibum - compr. film. - 30mg - antiinflamatoare si antireumatice nesteroidiene coxibi
etoricoxib terapia 60 mg
sun pharmaceutical industries europe b.v. - olanda - etoricoxibum - compr. film. - 60mg - antiinflamatoare si antireumatice nesteroidiene coxibi
etoricoxib terapia 90 mg
sun pharmaceutical industries europe b.v. - olanda - etoricoxibum - compr. film. - 90mg - antiinflamatoare si antireumatice nesteroidiene coxibi
etoricoxib terapia 120 mg
sun pharmaceutical industries europe b.v. - olanda - etoricoxibum - compr. film. - 120mg - antiinflamatoare si antireumatice nesteroidiene coxibi
tandesar 32 mg
sun pharmaceutical industries europe b.v. - olanda - candesartanum cilexetil - compr. - 32mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agenți antineoplazici - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.